Real-World Effectiveness of Cabotegravir + Rilpivirine vs Standard of Care Oral Regimens in the US
Background: In trials, long-acting (LA) injectable antiretroviral therapy (ART) with cabotegravir plus rilpivirine (CAB+RPV) was shown to be non-inferior to oral ART regimens in virologically suppressed (viral load [VL]